User profiles for Patrick F. Smith

Patrick Smith

Certara
Verified email at d3medicine.com
Cited by 4830

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised …

…, W Bradford, M Laughlin, NS Shulman, PF Smith - The Lancet, 2010 - thelancet.com
Background Present interferon-based standard of care treatment for chronic hepatitis C
virus (HCV) infection is limited by both efficacy and tolerability. We assessed the safety, …

Phase I and II Study of the Safety, Virologic Effect, and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-O-(3′,3′-Dimethylsuccinyl)Betulinic Acid (Bevirimat) …

PF Smith, A Ogundele, A Forrest, J Wilton… - Antimicrobial agents …, 2007 - Am Soc Microbiol
Bevirimat [3-O-(3′,3′-dimethylsuccinyl)betulinic acid] is the first in a new class of anti-human
immunodeficiency virus (HIV) drugs that inhibit viral maturation by specifically blocking …

Duo modules

AÇ Özcan, A Harmanci, PF Smith - Glasgow Mathematical Journal, 2006 - cambridge.org
LetRbe a ring. AnR-moduleM is called a (weak) duo moduleprovided every (direct summand)
submodule of M is fully invariant. It is proved that if R is a commutative domain with field of …

Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors

PF Smith, R DiCenzo, GD Morse - Clinical pharmacokinetics, 2001 - Springer
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a diverse group of compounds
that induce allosteric changes in the human immunodeficiency virus type 1 (HIV-1) reverse …

On the prime radical of a module over a commutative ring

J Jenkins, PF Smith - Communications in Algebra, 1992 - Taylor & Francis
Throughout this note, all rings are commutative and all modules are unitary. Let R be a ring
and M an R-module. We shall define the prime radical of M to be the intersection of M and all …

A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers

PF Smith, J Krishnarajah, PA Nunn… - British journal of …, 2017 - Wiley Online Library
Aim To evaluate the safety, tolerability, and pharmacokinetics/pharmacodynamics of
PRN1008, a novel Bruton's tyrosine kinase (BTK) inhibitor, in healthy volunteers, and thus …

Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers

DL Tomilo, PF Smith, AB Ogundele… - … : The Journal of …, 2006 - Wiley Online Library
Study Objective. To determine whether the pharmacokinetics of atazanavir, a protease
inhibitor used to treat human immunodeficiency virus (HIV) infection, are altered by its …

[PDF][PDF] Cyclic modules whose quotients have all complement submodules direct summands

BL Osofsky, PF Smith - Journal of algebra, 1991 - core.ac.uk
In [20, 21], Osofsky showed that a ring all of whose cyclic modules are injective is semisimple
Artinian. Since that time, a cyclic, finitely presented module version of the theorem has …

Dosing will be a key success factor in repurposing antivirals for COVID‐19.

PF Smith, M Dodds, D Bentley… - British journal of …, 2021 - search.ebscohost.com
For LPV, the steady-state total minimum plasma concentration (Cmin) at the standard HIV-1
treatment dose of 400/100 mg LPV/r is approximately 5 g/ml, or 0.075 g/ml of unbound (free) …

Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir

EF McCance-Katz, DE Moody, PF Smith… - Clinical infectious …, 2006 - academic.oup.com
We examined drug interactions between buprenorphine, an opioid partial agonist available
by prescription for treatment of opioid dependence, and the protease inhibitors (PIs) …